Citation Impact
Citing Papers
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
2009 Standout
Ribosomal S6 Kinase 2 Directly Phosphorylates the 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptor, Thereby Modulating 5-HT2A Signaling
2008
Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation
2015 StandoutNobel
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Agonist-induced regulation and trafficking of $kappa; opioid receptors
2004
The Active Conformation of β-Arrestin1
2007 StandoutNobel
Psychedelics and the Human Receptorome
2010
Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes
2006
Isolation and Chemical Modification of Clerodane Diterpenoids fromSalviaSpecies as Potential Agonists at theκ‐Opioid Receptor
2007
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
WAY-100635 is a potent dopamine D4 receptor agonist
2006
Novel neoclerodane diterpene derivatives from the smoke of salvinorin A
2010
Synthesis and biological evaluation of new salvinorin A analogues incorporating natural amino acids
2010
Kappa opioids promote the proliferation of astrocytes via Gβγ and β‐arrestin 2‐dependent MAPK‐mediated pathways
2008
Drug Addiction
2003
Receptor systems: Will mining the receptorome yield novel targets for pharmacotherapy?
2005
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human κ opioid receptors
2005
Predicting new molecular targets for known drugs
2009 Nature
Pattern of use and subjective effects of Salvia divinorum among recreational users
2006
Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats
2004
ChEMBL: a large-scale bioactivity database for drug discovery
2011 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues
2005
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Psychedelics
2016 Standout
How Ligands Illuminate GPCR Molecular Pharmacology
2017
Network medicine: a network-based approach to human disease
2010 Standout
Complete 1H and 13C NMR assignments of clerodane diterpenoids of Salvia splendens
2006
Molecular Dynamics Simulation for All
2018 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Ancient and Recent Positive Selection Transformed Opioid cis-Regulation in Humans
2005
Hallucinogens: An update
2003
Psychopharmacology of the hallucinogenic sage Salvia divinorum
2005
Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A
2010
Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues
2014
Drug repurposing: progress, challenges and recommendations
2018 Standout
Synthesis of 3‐Oxaterpenoids and Its Application in the Total Synthesis of (±)‐Moluccanic Acid Methyl Ester
2012
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Structure of the human κ-opioid receptor in complex with JDTic
2012 Nature
A new era of GPCR structural and chemical biology
2012 StandoutNobel
Short synthesis of a novel class of salvinorin A analogs with hemiacetalic structure
2008
The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro
2003
Large‐scale prediction of drug–target relationships
2008
The Mesolimbic Dopamine Reward Circuit in Depression
2006 Standout
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
In vitrostability and metabolism of salvinorin A in rat plasma
2009
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
2003
Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase‐1, C/EBP‐β and ILAD‐1, a novel gene with homology to arrestins
2004
The neural basis of psychedelic action
2022 Standout
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
2020
A Direct Interaction of PSD-95 with 5-HT2A Serotonin Receptors Regulates Receptor Trafficking and Signal Transduction
2003
Relating protein pharmacology by ligand chemistry
2007 Standout
The claustrum’s proposed role in consciousness is supported by the effect and target localization of Salvia divinorum
2014
Applications of machine learning in drug discovery and development
2019 Standout
An Opioid Agonist that Does Not Induce μ-Opioid Receptor—Arrestin Interactions or Receptor Internalization
2006
3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro
2003
Structure of the δ-opioid receptor bound to naltrindole
2012 StandoutNatureNobel
Biaryl Phosphane Ligands in Palladium‐Catalyzed Amination
2008 Standout
Empirical Studies Assessing the Quality of Health Information for Consumers on the World Wide Web
2002 Standout
Recent advances in selective opioid receptor agonists and antagonists
2003
Neurocircuitry of Addiction
2009 Standout
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
The promises and perils of psychedelic pharmacology for psychiatry
2022
The Interaction of a Constitutively Active Arrestin with the Arrestin-Insensitive 5-HT2A Receptor Induces Agonist-Independent Internalization
2003
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Constituents from Salvia Species and Their Biological Activities
2012 Standout
Convergent Synthesis of Complex Diketopiperazines Derived from Pipecolic Acid Scaffolds and Parallel Screening against GPCR Targets
2006
How structure informs and transforms chemogenetics
2019
Animal Models of Serotonergic Psychedelics
2012
p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling
2006
Synthesis of Glycopolymers for Microarray Applications via Ligation of Reducing Sugars to a Poly(acryloyl hydrazide) Scaffold
2010 StandoutNobel
A General Catalytic Asymmetric Prins Cyclization
2016 StandoutNobel
Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling
2014
Salvinorin C, a New Neoclerodane Diterpene from a Bioactive Fraction of the Hallucinogenic Mexican Mint Salvia divinorum
2001
Salvinicins A and B, New Neoclerodane Diterpenes from Salvia divinorum
2005
Guidelines for the Primary Prevention of Stroke
2014 Standout
Extended-Connectivity Fingerprints
2010 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
β-Arrestins and Cell Signaling
2007 StandoutNobel
Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior
2011
Molecular Docking: Shifting Paradigms in Drug Discovery
2019 Standout
Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?
2015 Standout
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
2013
Structure-based discovery of β 2 -adrenergic receptor ligands
2009 StandoutNobel
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development
2015
General Microarray Technique for Immobilization and Screening of Natural Glycans
2007
Thermal degradation products derived from the smoke of Salvia divinorum leaves
2010
β-Arrestin-biased ligands at seven-transmembrane receptors
2007 StandoutNobel
Second-generation synthesis of salvinorin A
2009
Synthesis of a Library of Complex Macrodiolides Employing Cyclodimerization of Hydroxy Esters
2005
An architectonic macrolide library based on a C2-symmetric macrodiolide toward pharmaceutical compositions
2015 StandoutNobel
Microglial M1/M2 polarization and metabolic states
2015 Standout
Salvinorins J from Salvia divinorum: Mutarotation in the Neoclerodane System
2009
Trafficking of G Protein–Coupled Receptors
2006 StandoutNobel
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Salvinorins D−F, New Neoclerodane Diterpenoids from Salvia divinorum, and an Improved Method for the Isolation of Salvinorin A
2003
Real-Time Bioluminescence Imaging of Glycans on Live Cells
2010 StandoutNobel
Hallucinogens
2004 Standout
Drug Information Libraries on the Internet
2000
Identification of Two Serine Residues Essential for Agonist-Induced 5-HT2AReceptor Desensitization
2003
Works of Daniel J. Siebert being referenced
Salvinorin A effect on rats when tested in a bioassay based on Hall's open field test
2006
Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia divinorum Is a Highly Efficacious κ-Opioid Receptor Agonist: Structural and Functional Considerations
2004
Antinociceptive and Hypothermic Effects of Salvinorin A Are Abolished in a Novel Strain of κ-Opioid Receptor-1 Knockout Mice
2006
Comparison of Pharmacological Activities of Three Distinct κ Ligands (Salvinorin A, TRK-820 and 3FLB) on κ Opioid Receptors in Vitro and Their Antipruritic and Antinociceptive Activities in Vivo
2004
Localization of Salvinorin A and Related Compounds in Glandular Trichomes of the Psychoactive Sage, Salvia divinorum
2004
Salvia divinorum and salvinorin A: new pharmacologic findings
1994
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
2002